Eric Baum

Unrivaled Brands, Inc. is a holding company, which engages in the retail, cultivation, and production of medical cannabis and agricultural products. It operates through the Cannabis Retail, and Cannabis Cultivation and Distribution segments. The Cannabis Retail segment includes cannabis-focused retail, both physical stores and non-store front delivery. The Cannabis Cultivation and Distribution segment includes cannabis cultivation, production, and distribution operations. The company was founded on July 22, 2008 and is headquartered in Santa Ana, CA.

KushCo Holdings, Inc. provided ancillary products and services to the legal cannabis and CBD industries. The firm through its subsidiaries and brands provides product quality, exceptional customer service, compliance knowledge and a local presence in serving diverse customer base. The company was founded by Dallas Imbimbo, John Kovacevich, Nicholas Kovacevich, and Jeffrey Meng on December 15, 2010 and was headquartered in Cypress, CA.

NewBridge Global Ventures, Inc. engages in the cultivation, manufacture, and distribution of medical and recreational cannabis. It also offers cannabis online education and consulting services. The company was founded by Ulrik Moll, Michael Maze, Mads H. Frederiksen and Morten Krarup in May 1983 and is headquartered in Alameda, CA.

Data Exchange Corp. provides supply chain solutions for high tech industries. It offers warehousing & distribution, reverse logistics, advanced exchange, procurement services, depot repair, and asset recovery program. The company was founded in 1980 by Sheldon Malchicoff and is headquartered in Camarillo, CA

ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY.

Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.

ESGAI Technologies, Inc. intends to identify, evaluate and then acquire an interest in a business or asset. The company was founded on February 18, 2015 and is headquartered in Vancouver, Canada.